Breakthrough trial aims to prevent arthritis in psoriasis patients

NCT ID NCT05004727

First seen Apr 08, 2026 · Last updated May 03, 2026 · Updated 2 times

Summary

This study tests whether the drug guselkumab can prevent psoriatic arthritis in people with psoriasis who are at high risk. About 176 adults with long-term psoriasis and early signs of joint inflammation will receive either guselkumab or standard care. The goal is to see if the drug reduces joint damage and stops arthritis from developing over two years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Brigham and Women's Hospital

    RECRUITING

    Boston, Massachusetts, 02115, United States

    Contact

    Contact

  • Memorial University

    RECRUITING

    St. John's, Newfoundland and Labrador, A1C 5B8, Canada

    Contact

    Contact Email: •••••@•••••

    Contact

  • NYU Langone Health

    RECRUITING

    New York, New York, 10016, United States

    Contact

    Contact

    Contact

    Contact

    Contact Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact Email: •••••@•••••

  • University of Rochester Medical Center (URMC)

    RECRUITING

    Rochester, New York, 14623, United States

    Contact Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

  • Women's College Research Institute, University of Toronto

    RECRUITING

    Toronto, Ontario, M5S 1B2, Canada

    Contact

    Contact Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.